価格表

在庫・価格 : 2025年04月26日 07時29分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Rictor, Rabbit-Poly
データシート
NB100-611 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥108,000
(未発注)
追加

在庫・価格 : 2025年04月26日 07時29分 現在

Anti-Rictor, Rabbit-Poly

  • 商品コード:NB100-611
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥108,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Breuleux M et al. Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Mol. Cancer Ther. 2009 Apr;8(4):742-53
Breuleux M et al
2009/01/01
PubMed
2 Yu K et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009 Aug;69(15):6232-40
Yu K et al
2009/01/01
PubMed
3 Ansell SM et al. Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study. Lancet Oncol. 2011 Apr;12(4):361-8
Ansell SM et al
2011/01/01
PubMed
4 He L et al. Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane. Role of TRB3 in inhibition of Akt/protein kinase B activation. J. Biol. Chem. 2006 Apr;281(16):11126-34
He L et al
2006/01/01
PubMed
5 Rosner M et al. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum. Mol. Genet. 2008 Oct;17(19):2934-48
Rosner M et al
2008/01/01
PubMed
6 Yu Y et al. Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J. Virol. 2008 May;82(9):4521-6
Yu Y et al
2008/01/01
PubMed
7 Dormond O et al. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J. Immunol. 2008 Dec;181(11):8088-95
Dormond O et al
2008/01/01
PubMed
8 Wang X et al. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation. Cancer Res. 2008 Sep;68(18):7409-18
Wang X et al
2008/01/01
PubMed
9 Urano J et al. Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2007 Feb;104(9):3514-9
Urano J et al
2007/01/01
PubMed
10 Fu L et al. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res. 2009 Dec;69(23):8967-76
Fu L et al
2009/01/01
PubMed
11 Copp J et al. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 2009 Mar;69(5):1821-7
Copp J et al
2009/01/01
PubMed
12 Schieke SM et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 2006 Sep;281(37):27643-52
Schieke SM et al
2006/01/01
PubMed
13 Shiota C et al. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 2006 Oct;11(4):583-9
Shiota C et al
2006/01/01
PubMed
14 Dan HC et al. Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha. Cancer Res. 2007 Jul;67(13):6263-9
Dan HC et al
2007/01/01
PubMed
15 Sato T et al. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J. Biol. Chem. 2009 May;284(19):12783-91
Sato T et al
2009/01/01
PubMed
16 Murata H et al. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J. Biol. Chem. 2011 Mar;286(9):7182-9
Murata H et al
2011/01/01
PubMed
17 Schieke SM et al. Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J. Biol. Chem. 2008 Oct;283(42):28506-12
Schieke SM et al
2008/01/01
PubMed
18 Thoreen CC et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 2009 Mar;284(12):8023-32
Thoreen CC et al
2009/01/01
PubMed
19 Jacinto E et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006 Oct;127(1):125-37
Jacinto E et al
2006/01/01
PubMed
20 Dibble CC et al. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 2009 Nov;29(21):5657-70
Dibble CC et al
2009/01/01
PubMed
21 Masri J et al. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res. 2007 Dec;67(24):11712-20
Masri J et al
2007/01/01
PubMed
22 Liu L et al. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J. Biol. Chem. 2010 Dec;285(49):38362-73
Liu L et al
2010/01/01
PubMed
23 Han EK et al. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Oncogene 2007 Aug;26(38):5655-61
Han EK et al
2007/01/01
PubMed
24 Dormond O et al. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J. Biol. Chem. 2007 Aug;282(32):23679-86
Dormond O et al
2007/01/01
PubMed
25 James MF et al. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. Mol. Cancer Res. 2012 May;10(5):649-59
James MF et al
2012/01/01
PubMed
26 Dan HC et al. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008 Jun;22(11):1490-500
Dan HC et al
2008/01/01
PubMed
27 Na誰mi M et al. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. Endocrinology 2007 May;148(5):2424-34
Na誰mi M et al
2007/01/01
PubMed
28 Huang J et al. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 2008 Jun;28(12):4104-15
Huang J et al
2008/01/01
PubMed
29 Lee HK et al. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell 2009 Mar;20(5):1533-44
Lee HK et al
2009/01/01
PubMed
30 Ohne Y et al. Isolation of hyperactive mutants of mammalian target of rapamycin. J. Biol. Chem. 2008 Nov;283(46):31861-70
Ohne Y et al
2008/01/01
PubMed
31 Hresko RC et al. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 2005 Dec;280(49):40406-16
Hresko RC et al
2005/01/01
PubMed
32 Beevers CS et al. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res. 2009 Feb;69(3):1000-8
Beevers CS et al
2009/01/01
PubMed
33 Shu L et al. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts. Mol. Cell. Biol. 2009 Sep;29(17):4691-700
Shu L et al
2009/01/01
PubMed
  • No.: 1
  • 文献情報:
    Breuleux M et al. Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Mol. Cancer Ther. 2009 Apr;8(4):742-53
    Breuleux M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yu K et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009 Aug;69(15):6232-40
    Yu K et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ansell SM et al. Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study. Lancet Oncol. 2011 Apr;12(4):361-8
    Ansell SM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    He L et al. Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane. Role of TRB3 in inhibition of Akt/protein kinase B activation. J. Biol. Chem. 2006 Apr;281(16):11126-34
    He L et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Rosner M et al. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum. Mol. Genet. 2008 Oct;17(19):2934-48
    Rosner M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Yu Y et al. Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J. Virol. 2008 May;82(9):4521-6
    Yu Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Dormond O et al. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J. Immunol. 2008 Dec;181(11):8088-95
    Dormond O et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wang X et al. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation. Cancer Res. 2008 Sep;68(18):7409-18
    Wang X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Urano J et al. Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2007 Feb;104(9):3514-9
    Urano J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Fu L et al. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res. 2009 Dec;69(23):8967-76
    Fu L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Copp J et al. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 2009 Mar;69(5):1821-7
    Copp J et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Schieke SM et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 2006 Sep;281(37):27643-52
    Schieke SM et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Shiota C et al. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 2006 Oct;11(4):583-9
    Shiota C et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Dan HC et al. Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha. Cancer Res. 2007 Jul;67(13):6263-9
    Dan HC et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Sato T et al. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J. Biol. Chem. 2009 May;284(19):12783-91
    Sato T et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Murata H et al. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J. Biol. Chem. 2011 Mar;286(9):7182-9
    Murata H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Schieke SM et al. Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J. Biol. Chem. 2008 Oct;283(42):28506-12
    Schieke SM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Thoreen CC et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 2009 Mar;284(12):8023-32
    Thoreen CC et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Jacinto E et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006 Oct;127(1):125-37
    Jacinto E et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Dibble CC et al. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 2009 Nov;29(21):5657-70
    Dibble CC et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Masri J et al. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res. 2007 Dec;67(24):11712-20
    Masri J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Liu L et al. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J. Biol. Chem. 2010 Dec;285(49):38362-73
    Liu L et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Han EK et al. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Oncogene 2007 Aug;26(38):5655-61
    Han EK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Dormond O et al. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J. Biol. Chem. 2007 Aug;282(32):23679-86
    Dormond O et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    James MF et al. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. Mol. Cancer Res. 2012 May;10(5):649-59
    James MF et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Dan HC et al. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008 Jun;22(11):1490-500
    Dan HC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Na誰mi M et al. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. Endocrinology 2007 May;148(5):2424-34
    Na誰mi M et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Huang J et al. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 2008 Jun;28(12):4104-15
    Huang J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Lee HK et al. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell 2009 Mar;20(5):1533-44
    Lee HK et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Ohne Y et al. Isolation of hyperactive mutants of mammalian target of rapamycin. J. Biol. Chem. 2008 Nov;283(46):31861-70
    Ohne Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Hresko RC et al. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 2005 Dec;280(49):40406-16
    Hresko RC et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Beevers CS et al. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res. 2009 Feb;69(3):1000-8
    Beevers CS et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Shu L et al. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts. Mol. Cell. Biol. 2009 Sep;29(17):4691-700
    Shu L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed